                         SEQUENCE LISTING

<110>  3D BIO-TISSUES LIMITED
 
<120>  COLLAGEN PRODUCTION

<130>  P277330WO

<140>  PCT/GB2020/053190
<141>  2020-12-11

<150>  GB1918167.6
<151>  2019-12-11

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ETTES peptide

<400>  1

Glu Thr Thr Glu Ser 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  KTTKS peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  C16

<400>  2

Lys Thr Thr Lys Ser 
1               5   


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell adhesion moiety

<400>  3

Arg Gly Asp Ser 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ETTE peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  C16

<400>  4

Glu Thr Thr Glu 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ETTES Fragment

<400>  5

Thr Thr Glu Ser 
1               


<210>  6
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ETTES Variant

<400>  6

Glu Thr Glu Thr Ser 
1               5   


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ETTES Variant

<400>  7

Thr Thr Glu Glu Ser 
1               5   


<210>  8
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ETTES Variant

<400>  8

Ser Glu Glu Thr Thr 
1               5   


<210>  9
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ETTES Variant

<400>  9

Ser Glu Thr Glu Thr 
1               5   


<210>  10
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ETTES Variant

<400>  10

Thr Glu Ser Thr Glu 
1               5   


